| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 127.89B | 112.73B | 131.94B | 131.29B | 161.71B | 134.55B |
| Gross Profit | 7.47B | 6.53B | 7.57B | 7.34B | 8.26B | 7.67B |
| EBITDA | 5.42B | 4.75B | 5.50B | 5.18B | 5.50B | 4.33B |
| Net Income | -2.86B | 283.00M | -2.51B | 1.02B | 637.00M | 1.57B |
Balance Sheet | ||||||
| Total Assets | 72.28B | 75.81B | 73.63B | 79.02B | 84.78B | 73.37B |
| Cash, Cash Equivalents and Short-Term Investments | 11.82B | 10.60B | 11.56B | 10.27B | 9.75B | 7.93B |
| Total Debt | 33.00B | 34.08B | 31.75B | 35.83B | 38.23B | 26.70B |
| Total Liabilities | 57.18B | 58.66B | 58.30B | 59.30B | 66.77B | 56.28B |
| Stockholders Equity | 15.07B | 17.11B | 15.29B | 19.70B | 18.00B | 17.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -942.00M | 7.87B | 4.71B | -2.64B | -5.95B |
| Operating Cash Flow | 0.00 | 2.59B | 10.35B | 8.66B | 361.00M | -3.51B |
| Investing Cash Flow | 0.00 | -4.33B | -3.65B | -4.74B | -8.76B | -2.09B |
| Financing Cash Flow | 0.00 | 575.00M | -5.57B | -3.45B | 10.14B | 6.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥927.58B | 27.98 | 8.07% | 2.85% | 11.53% | 1.60% | |
70 Outperform | ¥75.35B | 19.94 | ― | 3.05% | 8.87% | -12.83% | |
68 Neutral | ¥17.75T | 75.03 | 8.95% | 1.88% | 5.02% | 2.02% | |
66 Neutral | ¥425.58B | 15.21 | 11.96% | 3.04% | 2.93% | -26.76% | |
64 Neutral | ¥7.80T | 39.87 | ― | 1.41% | 13.61% | 17.01% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
46 Neutral | ¥6.84B | 24.06 | -14.16% | 2.98% | -14.56% | ― |